ArticleFrontiers in endocrinology2026
The RASA2/RASA3 ortholog RasGAP1 modulates obesity-linked phenotypes and is associated with leptin-analog signaling in
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Obesity arises from the interplay between genetic predisposition, metabolic signaling, and neural circuits that regulate feeding and energy expenditure. Large-scale association studies repeatedly implicate regulators of Ras/Rap GTPase signaling in adiposity and metabolic risk, but the mechanisms linking these intracellular switch modules to neural control of energy balance remain unclear. Methods: We used a translational approach centered on Drosophila RasGAP1, the closest ortholog of mammalian RASA2/3. Pan-neuronal RasGAP1 knockdown was assessed for effects on locomotor behavior, feeding interactions, systemic metabolic markers, expression of the leptin analog unpaired 1 (upd1), and protein-interaction networks. We then extended these findings to humans using protein-network and phenome-wide association analyses focused on RASA2/3-related pathways. Results: Pan-neuronal RasGAP1 knockdown shifted behavior toward an obesity-like phenotype, combining reduced locomotor output with increased feeding interactions. This was accompanied by elevated lipid storage, increased circulating sugars, and reduced expression of upd1. Protein-interactome mapping positioned RasGAP1 within a connected signaling neighborhood linking Ras signaling with cytokine pathways relevant to feeding control. In humans, protein-network and phenome-wide association analyses converged on a KRAS-centered pathway in which RASA2/3, KRAS, and LEP were consistently associated with fat mass, BMI, and lipid dysregulation. Discussion: These findings support RasGAP1/RASA2/3 as a candidate conserved neuro-metabolic regulator. More broadly, they provide hypothesis-generating evidence that RasGAP dysfunction may bias neural and metabolic control systems toward adiposity-linked phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.